Description:
Trox-S 1.5 g is a combipack / injectable antibiotic formulation combining ceftriaxone + sulbactam, used to treat serious bacterial infections by extending the spectrum via β-lactamase inhibition.

Prescription:
Yes — this is a prescription-only injectable antibiotic.

Therapeutic Category:
Antibacterial / antibiotic — cephalosporin (third generation) combined with a β-lactamase inhibitor.

Active Ingredients / Composition:

• Ceftriaxone (presumably 1.0 g)
• Sulbactam (presumably 0.5 g) (making up a total of 1.5 g in the combi pack) 
• Excipients (sterile diluent, buffers, etc.) as per formulation (not publicly detailed in the sources I found)
  

Variant:
Injectable formulation (sterile powder or solution intended for injection). The “combipack” suggests the antibiotic vials plus diluent are packaged together. 

Consume Type:
Parenteral — administered by injection (intravenous or intramuscular, as per standard ceftriaxone / sulbactam protocols).

Directions / Usage:

• Administered by a healthcare professional.
• The appropriate dosing frequency and route (IV vs IM) depends on the infection type, severity, and patient status.
• Because the product is a fixed combination, you would follow the prescribing instructions corresponding to ceftriaxone + sulbactam guidelines (e.g. once or twice daily).
• Use in reconstituted form (with supplied diluent) and ensure sterility.

Common Side Effects:
Side effects typical of ceftriaxone/sulbactam combinations include:

• Local injection site reactions (pain, swelling)
• Gastrointestinal disturbances (nausea, diarrhoea)
• Allergic reactions (rash, itching)
• Alteration of liver enzymes or hepatic function
• Changes in blood cell counts (rare)
• Possible superinfection (overgrowth of non-susceptible organisms)
• Potential kidney effects (in susceptible patients)
  

Package Type:
Combi pack: e.g. vial(s) containing the antibiotic and a 10 mL diluent (sterile water or buffer) for reconstitution. 

Storage Advice:

• Store the vials (powder) under controlled room temperature as per label.
• Protect from moisture and light.
• After reconstitution, use the solution promptly (within time limit as specified on insert).
• Keep sterile; do not use if contamination occurs.
  

Safety Advice:

• Contraindicated in patients allergic to cephalosporins, penicillins, or β-lactam antibiotics.
• Use caution in patients with severe renal or hepatic impairment; dose adjustment may be necessary.
• Monitor for signs of hypersensitivity (anaphylaxis) especially in those with prior β-lactam allergies.
• Be cautious in patients with biliary disease (since ceftriaxone is excreted partly via bile).
• Use with caution in neonates or young infants (depending on local labelling).
• Avoid concomitant use with other nephrotoxic or hepatotoxic drugs without monitoring.
• Ensure proper dilution and administration technique to avoid local tissue irritation or precipitate formation.
• If severe diarrhoea develops (especially bloody), evaluate for Clostridioides difficile infection.
• Do not use beyond the expiry date or if vial integrity is compromised.
  

Product Substitutes:

• Other ceftriaxone + sulbactam injections (generic combinations)
• Depending on local antimicrobial susceptibility, monotherapy with ceftriaxone (if sulbactam not needed) or alternative broad-spectrum antibiotics as per clinician decision.
  

Manufacturer / Marketer:
M&G Pharmaceuticals

Country of Origin:
Ghana